Suppr超能文献

氟康唑在兔体内的药代动力学及组织穿透性

Pharmacokinetics and tissue penetration of fluconazole in rabbits.

作者信息

Walsh T J, Foulds G, Pizzo P A

机构信息

Pediatric Branch, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Antimicrob Agents Chemother. 1989 Apr;33(4):467-9. doi: 10.1128/AAC.33.4.467.

Abstract

Fluconazole is a new bis-triazole antifungal compound which has in vivo and in vitro activity against Candida spp. and Cryptococcus neoformans and excellent penetration into cerebrospinal fluid. However, little is known about the penetration of fluconazole into tissue sites other than cerebrospinal fluid. We therefore studied by high-pressure liquid chromatography the penetration of fluconazole into nine different tissue sites at times of peak and trough concentrations in plasma in rabbits. Fluconazole penetrated into all tissue sites. Tissue/plasma concentration ratios were greater at time of trough concentrations in plasma than at times of peak concentrations in plasma. The finding that fluconazole penetrated into target organs commonly infected by Candida spp. and C. neoformans further supports the therapeutic potential of fluconazole for disseminated candidiasis or cryptococcosis in immunocompromised hosts.

摘要

氟康唑是一种新型双三唑类抗真菌化合物,具有体内外抗念珠菌属和新型隐球菌的活性,且能很好地穿透进入脑脊液。然而,除脑脊液外,对于氟康唑在其他组织部位的穿透情况了解甚少。因此,我们通过高压液相色谱法研究了兔血浆中氟康唑浓度达峰和谷时在九个不同组织部位的穿透情况。氟康唑可穿透进入所有组织部位。组织/血浆浓度比在血浆谷浓度时高于血浆峰浓度时。氟康唑可穿透进入念珠菌属和新型隐球菌常见感染的靶器官这一发现,进一步支持了氟康唑对免疫功能低下宿主播散性念珠菌病或隐球菌病的治疗潜力。

相似文献

1
Pharmacokinetics and tissue penetration of fluconazole in rabbits.
Antimicrob Agents Chemother. 1989 Apr;33(4):467-9. doi: 10.1128/AAC.33.4.467.
2
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
Antimicrob Agents Chemother. 1989 Oct;33(10):1735-40. doi: 10.1128/AAC.33.10.1735.
3
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Antimicrob Agents Chemother. 1996 Oct;40(10):2237-42. doi: 10.1128/AAC.40.10.2237.
4
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Antimicrob Agents Chemother. 1997 Jan;41(1):30-4. doi: 10.1128/AAC.41.1.30.
5
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Antimicrob Agents Chemother. 1996 Aug;40(8):1910-3. doi: 10.1128/AAC.40.8.1910.
6
New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans and .
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01628-19.
7
In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans.
Antimicrob Agents Chemother. 1998 Oct;42(10):2630-2. doi: 10.1128/AAC.42.10.2630.
8
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Antimicrob Agents Chemother. 2004 Feb;48(2):384-7. doi: 10.1128/AAC.48.2.384-387.2004.
9
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00546-19. Print 2019 Sep.

引用本文的文献

1
Human Tissue Distribution of Anidulafungin and Micafungin.
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0016921. doi: 10.1128/AAC.00169-21.
4
Pros and Cons of Extrapolating Animal Data on Antifungal Pharmacodynamics to Humans.
Curr Fungal Infect Rep. 2011 Jun;5(2):59-66. doi: 10.1007/s12281-011-0051-0. Epub 2011 Mar 26.
5
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
6
Tissue penetration of antifungal agents.
Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.
7
Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action.
Clin Pharmacokinet. 2002;41(8):581-602. doi: 10.2165/00003088-200241080-00003.
8
Candiduria: When and How to Treat It.
Curr Infect Dis Rep. 2000 Dec;2(6):523-530. doi: 10.1007/s11908-000-0056-2.
9
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Antimicrob Agents Chemother. 2000 Nov;44(11):2932-8. doi: 10.1128/AAC.44.11.2932-2938.2000.

本文引用的文献

1
Cryptococcemia.
Medicine (Baltimore). 1983 Mar;62(2):98-109. doi: 10.1097/00005792-198303000-00003.
2
Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.
Ann Intern Med. 1988 Jan;108(1):88-100. doi: 10.7326/0003-4819-108-1-88.
5
Cryptococcal meningitis and fluconazole.
Ann Intern Med. 1987 May;106(5):778. doi: 10.7326/0003-4819-106-5-778_2.
6
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
J Antimicrob Chemother. 1985 Jul;16(1):81-6. doi: 10.1093/jac/16.1.81.
7
Fluconazole penetration into cerebrospinal fluid in humans.
J Clin Pharmacol. 1988 Apr;28(4):363-6. doi: 10.1002/j.1552-4604.1988.tb03159.x.
8
Azole antifungal agents: emphasis on new triazoles.
Antimicrob Agents Chemother. 1988 Jan;32(1):1-8. doi: 10.1128/AAC.32.1.1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验